These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18437072)
1. Progress in prevention: raising the bar to lower blood pressure: key steps to improve blood pressure control rates. Dennison CR; Hughes S J Cardiovasc Nurs; 2008; 23(3):293-4. PubMed ID: 18437072 [No Abstract] [Full Text] [Related]
2. Hypertension in Mississippi: we can do better. Jones DW J Miss State Med Assoc; 2009 Feb; 50(2):39-42. PubMed ID: 19297944 [TBL] [Abstract][Full Text] [Related]
3. Public health and the control of high blood pressure at the state level: asleep at the switch or running low on fuel? Mensah GA Circulation; 2008 Feb; 117(7):860-2. PubMed ID: 18285575 [No Abstract] [Full Text] [Related]
4. [Blood pressure-lowering treatment for the reduction of the cardiovascular complications of hypertension]. Birkenhäger WH Ned Tijdschr Geneeskd; 1985 Dec; 129(49):2341-3. PubMed ID: 4088334 [No Abstract] [Full Text] [Related]
6. [The pharmacotherapy of arterial hypertension and the prevention of cardiovascular events. From evidence-based medicine to the new therapeutic opportunities]. Taddei S Recenti Prog Med; 1999 Jan; 90(1):4-8. PubMed ID: 10193156 [No Abstract] [Full Text] [Related]
7. Practical strategies for management of hypertension in the elderly. Gibson MV; Fritz J; Kachur V Geriatrics; 2009 Oct; 64(10):10-9. PubMed ID: 20726383 [No Abstract] [Full Text] [Related]
8. [Cardiovascular prevention: not necessary under the age of 40]. Walma EP Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804 [TBL] [Abstract][Full Text] [Related]
9. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. Giese M; Lackland DT; Egan BM J S C Med Assoc; 2001 Feb; 97(2):57-62. PubMed ID: 11235117 [No Abstract] [Full Text] [Related]
11. Initiation of therapy for patients with essential hypertension or comorbid conditions. Wexler R; Feldman D Prim Care; 2006 Dec; 33(4):887-901. PubMed ID: 17169672 [TBL] [Abstract][Full Text] [Related]
12. The treatment of hypertension in Canada: are we making progress? McAlister FA CMAJ; 1999 Sep; 161(6):713-4. PubMed ID: 10513278 [No Abstract] [Full Text] [Related]
13. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved. Probstfield J J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849 [No Abstract] [Full Text] [Related]
14. Clinical inquiries. What is the best way to treat patients with white-coat hypertension? Rao S; Liu CT; Wilder L; Stephens MB J Fam Pract; 2004 May; 53(5):408-12. PubMed ID: 15125828 [No Abstract] [Full Text] [Related]
16. Diabetes and hypertension: which is the best approach? Escobar C; Barrios V Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):269-71. PubMed ID: 19296764 [TBL] [Abstract][Full Text] [Related]
18. Tips for the use of antihypertensive drugs: DELTAREPROSI. Bianchetti MG; Ardissino G; Fossali E; Ramelli GP; Salice P J Pediatr; 2004 Sep; 145(3):288-90. PubMed ID: 15343175 [No Abstract] [Full Text] [Related]
19. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?]. Schmieder RE Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556 [No Abstract] [Full Text] [Related]